Viewing Study NCT00191464



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00191464
Status: COMPLETED
Last Update Posted: 2010-10-13
First Post: 2005-09-12

Brief Title: Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Study Overview

Official Title: Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes A Comparison of Premeal Insulin Lispro Mixtures to Once-Daily Insulin Glargine
Status: COMPLETED
Status Verified Date: 2010-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary objective of this study is to show that a prandial insulin regimen consisting of premeal insulin lispro mid mixture or a combined regimen of insulin lispro mid mixture and insulin lispro low mixture plus metformin will result in significantly better overall glycemic control lower HbA1c at endpoint than once-daily insulin glargine plus metformin Insulin lispro mid mixture consists of 50 insulin lispro and 50 NPL Insulin lispro low mixture consists of 25 insulin lispro and 75 NPL

In a substudy of approximately 60 patients additional data will be collected on markers associated with risk of atherosclerosis or cardiovascular disease in the context of a controlled outpatient high-fat test meal
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
F3Z-MC-IOOI None None None